Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 237

1.

Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau: a prospective open cohort study.

Esbjörnsson J, Månsson F, Kvist A, da Silva ZJ, Andersson S, Fenyö EM, Isberg PE, Biague AJ, Lindman J, Palm AA, Rowland-Jones SL, Jansson M, Medstrand P, Norrgren H; Sweden and Guinea-Bissau Cohort Research Group.

Lancet HIV. 2018 Nov 1. pii: S2352-3018(18)30254-6. doi: 10.1016/S2352-3018(18)30254-6. [Epub ahead of print]

PMID:
30392769
2.

Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition.

Sheik-Khalil E, Bray MA, Özkaya Şahin G, Scarlatti G, Jansson M, Carpenter AE, Fenyö EM.

BMC Infect Dis. 2014 Aug 30;14:472. doi: 10.1186/1471-2334-14-472.

3.

Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals.

Esbjörnsson J, Månsson F, Kvist A, Isberg PE, Biague AJ, da Silva ZJ, Jansson M, Fenyö EM, Norrgren H, Medstrand P.

AIDS. 2014 Apr 24;28(7):949-57.

PMID:
24812673
4.

Effect of HIV-2 infection on HIV-1 disease progression and mortality.

Esbjörnsson J, Månsson F, Kvist A, Isberg PE, Nowroozalizadeh S, Biague AJ, da Silva ZJ, Jansson M, Fenyö EM, Norrgren H, Medstrand P.

AIDS. 2014 Feb 20;28(4):614-5. doi: 10.1097/QAD.0000000000000142. No abstract available.

PMID:
24469002
5.

High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch.

Mild M, Gray RR, Kvist A, Lemey P, Goodenow MM, Fenyö EM, Albert J, Salemi M, Esbjörnsson J, Medstrand P.

Infect Genet Evol. 2013 Oct;19:369-77. doi: 10.1016/j.meegid.2013.05.004. Epub 2013 May 11.

PMID:
23672855
6.

Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection.

Özkaya Şahin G, Månsson F, Palm AA, Vincic E, da Silva Z, Medstrand P, Norrgren H, Fenyö EM, Jansson M.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):470-8. doi: 10.1089/AID.2012.0219. Epub 2012 Nov 21.

7.

Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.

Özkaya Şahin G, Holmgren B, Sheik-Khalil E, da Silva Z, Nielsen J, Nowroozalizadeh S, Månsson F, Norrgren H, Aaby P, Fenyö EM, Jansson M.

J Virol. 2013 Jan;87(1):273-81. doi: 10.1128/JVI.01640-12. Epub 2012 Oct 17.

8.

Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection.

Esbjörnsson J, Månsson F, Kvist A, Isberg PE, Nowroozalizadeh S, Biague AJ, da Silva ZJ, Jansson M, Fenyö EM, Norrgren H, Medstrand P.

N Engl J Med. 2012 Jul 19;367(3):224-32. doi: 10.1056/NEJMoa1113244.

9.

International network for comparison of HIV neutralization assays: the NeutNet report II.

Heyndrickx L, Heath A, Sheik-Khalil E, Alcami J, Bongertz V, Jansson M, Malnati M, Montefiori D, Moog C, Morris L, Osmanov S, Polonis V, Ramaswamy M, Sattentau Q, Tolazzi M, Schuitemaker H, Willems B, Wrin T, Fenyö EM, Scarlatti G.

PLoS One. 2012;7(5):e36438. doi: 10.1371/journal.pone.0036438. Epub 2012 May 9.

10.

Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1.

Ozkaya Sahin G, Holmgren B, da Silva Z, Nielsen J, Nowroozalizadeh S, Esbjörnsson J, Månsson F, Andersson S, Norrgren H, Aaby P, Jansson M, Fenyö EM.

J Virol. 2012 Jan;86(2):961-71. doi: 10.1128/JVI.06315-11. Epub 2011 Nov 9.

11.

Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance.

Fenyö EM, Esbjörnsson J, Medstrand P, Jansson M.

J Intern Med. 2011 Dec;270(6):520-31. doi: 10.1111/j.1365-2796.2011.02455.x. Epub 2011 Oct 27.

12.

Sequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countries.

Vinner L, Holmgren B, Jensen KJ, Esbjornsson J, Borggren M, Hentze JL, Karlsson I, Andresen BS, Gram GJ, Kloverpris H, Aaby P, Da Silva ZJ, Fenyö EM, Fomsgaard A.

APMIS. 2011 Aug;119(8):487-97. doi: 10.1111/j.1600-0463.2011.02763.x. Epub 2011 May 14.

PMID:
21749448
13.

Increased sensitivity to broadly neutralizing antibodies of end-stage disease R5 HIV-1 correlates with evolution in Env glycosylation and charge.

Borggren M, Repits J, Sterjovski J, Uchtenhagen H, Churchill MJ, Karlsson A, Albert J, Achour A, Gorry PR, Fenyö EM, Jansson M.

PLoS One. 2011;6(6):e20135. doi: 10.1371/journal.pone.0020135. Epub 2011 Jun 16.

14.

Inhibition of splicing by serine-arginine rich protein 55 (SRp55) causes the appearance of partially spliced HIV-1 mRNAs in the cytoplasm.

Tranell A, Tingsborg S, Fenyö EM, Schwartz S.

Virus Res. 2011 Apr;157(1):82-91. doi: 10.1016/j.virusres.2011.02.010. Epub 2011 Feb 21.

PMID:
21345357
15.

High prevalence of HIV-1, HIV-2 and other sexually transmitted infections among women attending two sexual health clinics in Bissau, Guinea-Bissau, West Africa.

Månsson F, Camara C, Biai A, Monteiro M, da Silva ZJ, Dias F, Alves A, Andersson S, Fenyö EM, Norrgren H, Unemo M.

Int J STD AIDS. 2010 Sep;21(9):631-5. doi: 10.1258/ijsa.2010.009584.

PMID:
21097735
16.

Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy.

Ozkaya Sahin G, Bowles EJ, Parker J, Uchtenhagen H, Sheik-Khalil E, Taylor S, Pybus OG, Mäkitalo B, Walther-Jallow L, Spångberg M, Thorstensson R, Achour A, Fenyö EM, Stewart-Jones GB, Spetz AL.

PLoS Pathog. 2010 Sep 2;6(9):e1001084. doi: 10.1371/journal.ppat.1001084.

17.

Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3.

Tranell A, Fenyö EM, Schwartz S.

J Biol Chem. 2010 Oct 8;285(41):31537-47. doi: 10.1074/jbc.M109.077453. Epub 2010 Aug 4.

18.

Flexible use of CCR5 in the absence of CXCR4 use explains the immune deficiency in HIV-1 infected children.

Cavarelli M, Karlsson I, Ripamonti C, Plebani A, Fenyo EM, Scarlatti G.

AIDS. 2010 Oct 23;24(16):2527-33. doi: 10.1097/QAD.0b013e32833d7d8c.

PMID:
20683317
19.

High sexual risk taking and diverging trends of HIV-1 and HIV-2 in the military of Guinea Bissau.

Biague A, Månsson F, da Silva Z, Dias F, Nantote Q, Costa J, Andersson S, Nauclér A, Biberfeld G, Fenyö EM, Norrgren H.

J Infect Dev Ctries. 2010 Jun 3;4(5):301-8.

20.

Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa.

Esbjörnsson J, Månsson F, Martínez-Arias W, Vincic E, Biague AJ, da Silva ZJ, Fenyö EM, Norrgren H, Medstrand P.

Retrovirology. 2010 Mar 22;7:23. doi: 10.1186/1742-4690-7-23.

Supplemental Content

Loading ...
Support Center